Pharmacovigilance Outsourcing Market Size, Share and Forecast 2032
Pharmacovigilance Outsourcing Market - By Service Provider (Business Processing Outsourcing and Contract Research Organizations), By Service (Post-marketing Services (IT Solutions & Services and Knowledge Process Outsourcing Services) and Pre-marketing Services (Case-Processing Services, Clinical Pharmacovigilance Services, Medical Review, and Safety Data Management Services)), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.76 Billion | USD 13.05 Billion | 14.84% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
- 2.2. Pharmacovigilance Outsourcing Market: Snapshot
- Chapter 3. Global Pharmacovigilance Outsourcing Market– Industry Analysis
- 3.1. Pharmacovigilance Outsourcing Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Need for reduction in costs of in-house pharmacovigilance system maintenance
- 3.2.2. High requirement to reduce infrastructural costs
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Service Provider
- 3.4.2. Market attractiveness analysis By Service
- Chapter 4. Global Pharmacovigilance Outsourcing Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Pharmacovigilance Outsourcing Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Pharmacovigilance Outsourcing Market–Service Provider Analysis
- 5.1. Global Pharmacovigilance Outsourcing Market overview: By Service Provider
- 5.1.1. Global Pharmacovigilance Outsourcing Market share, By Service Provider,2019 and 2026
- 5.2. Business Processing Outsourcing
- 5.2.1. Global Pharmacovigilance Outsourcing Market by Business Processing Outsourcing, 2016–2026(USD Billion)
- 5.3. Contract Research Organizations
- 5.3.1. Global Pharmacovigilance Outsourcing Market by Contract Research Organizations, 2016–2026(USD Billion)
- 5.1. Global Pharmacovigilance Outsourcing Market overview: By Service Provider
- Chapter 6. Global Pharmacovigilance Outsourcing Market– Service Analysis
- 6.1. Global Pharmacovigilance Outsourcing Market overview: By Service
- 6.1.1. Global Pharmacovigilance Outsourcing Market share, By Service , 2019 and 2026
- 6.2. Post-marketing Services
- 6.2.1. Global Pharmacovigilance Outsourcing Market By Post-marketing Services, 2016–2026(USD Billion)
- 6.3. Pre-marketing Services
- 6.3.1. Global Pharmacovigilance Outsourcing Market By Pre-marketing Services, 2016–2026(USD Billion)
- 6.1. Global Pharmacovigilance Outsourcing Market overview: By Service
- Chapter 7. Company Profiles
- 7.1. Bioclinica
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Accenture
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Clintec
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. CliniRx Tangent Research
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Covance
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Cognizant
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Genpact
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. Ergomed
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. IBM
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. HCL Technologies
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Product Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. iGATE
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Product Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. ICON
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Product Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Infosys
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Product Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. iMED Global
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Product Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. IQVIA
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Product Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Medpace Huldings
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Product Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. Oracle
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Product Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.18. Novartis
- 7.18.1. Overview
- 7.18.2. Financials
- 7.18.3. Product Portfolio
- 7.18.4. Business Strategy
- 7.18.5. Recent Development
- 7.19. PRA Health Sciences
- 7.19.1. Overview
- 7.19.2. Financials
- 7.19.3. Product Portfolio
- 7.19.4. Business Strategy
- 7.19.5. Recent Development
- 7.20. Parexel
- 7.20.1. Overview
- 7.20.2. Financials
- 7.20.3. Product Portfolio
- 7.20.4. Business Strategy
- 7.20.5. Recent Development
- 7.21. Symogen
- 7.21.1. Overview
- 7.21.2. Financials
- 7.21.3. Product Portfolio
- 7.21.4. Business Strategy
- 7.21.5. Recent Development
- 7.22. SIRO Clinpharm
- 7.22.1. Overview
- 7.22.2. Financials
- 7.22.3. Product Portfolio
- 7.22.4. Business Strategy
- 7.22.5. Recent Development
- 7.23. Tata Consultancy Services (TCS)
- 7.23.1. Overview
- 7.23.2. Financials
- 7.23.3. Product Portfolio
- 7.23.4. Business Strategy
- 7.23.5. Recent Development
- 7.24. Tech Mahindra
- 7.24.1. Overview
- 7.24.2. Financials
- 7.24.3. Product Portfolio
- 7.24.4. Business Strategy
- 7.24.5. Recent Development
- 7.25. Syneos Health
- 7.25.1. Overview
- 7.25.2. Financials
- 7.25.3. Product Portfolio
- 7.25.4. Business Strategy
- 7.25.5. Recent Development
- 7.1. Bioclinica
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Pharmacovigilance Outsourcing Market attractiveness, By Service Provider
6. Global Pharmacovigilance Outsourcing Market attractiveness, By Service
7. Global Pharmacovigilance Outsourcing Market share, By Service Provider, 2019 and 2026 (USD Billion)
8. Global Pharmacovigilance Outsourcing Market by Business Processing Outsourcing, 2016–2026(USD Billion)
9. Global Pharmacovigilance Outsourcing Market by Contract Research Organizations,2016–2026(USD Billion)
10. Global Pharmacovigilance Outsourcing Market Share by Service ,2019 and 2026 (USD Billion)
11. Global Pharmacovigilance Outsourcing Market by Post-marketing Services, 2016–2026(USD Billion)
12. Global Pharmacovigilance Outsourcing Market by Pre-marketing Services, 2016–2026(USD Billion)
13. Global Pharmacovigilance Outsourcing Market share, by Region, 2019 and 2026
14. North America Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
15. Europe Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
16. Asia Pacific Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
17. Latin America Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
18. The Middle East and Africa Pharmacovigilance Outsourcing Market, 2016–2026(USD Billion)
Table Of Tables
List of Tables
1. Global Pharmacovigilance Outsourcing Market: snapshot
2. Drivers of the Pharmacovigilance Outsourcing Market: impact analysis
3. North America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
4. North America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
5. The U.S. Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
6. The U.S. Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
7. Rest of North America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
8. Rest of North America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
9. Europe Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
10. Europe Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
11. UK Pharmacovigilance Outsourcing Market revenue, By Service Provider ,2016–2026(USD Billion)
12. UK Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
13. France Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
14. France Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
15. Germany Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
16. Germany Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
17. Rest of Europe Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
18. Rest of Europe Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
19. Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
20. Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
21. China Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
22. China Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
23. Japan Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
24. Japan Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
25. India Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
26. India Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
27. Rest of Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
28. Rest of Asia Pacific Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
29. Latin America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
30. Latin America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
31. Brazil Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
32. Brazil Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
33. Rest of Latin America Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
34. Rest of Latin America Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
35. The Middle East and Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
36. The Middle East and Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
37. Saudi Arabia Pharmacovigilance Outsourcing Market revenue, By Service Provider, 2016–2026(USD Billion)
38. Saudi Arabia Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
39. South Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
40. South Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
41. Rest of the Middle East & Africa Pharmacovigilance Outsourcing Market revenue, By Service Provider,2016–2026(USD Billion)
42. Rest of the Middle East & Africa Pharmacovigilance Outsourcing Market revenue, By Service , 2016–2026(USD Billion)
Methodology
FrequentlyAsked Questions
Pharmacovigilance outsourcing delegates drug safety monitoring to specialists. It ensures regulatory compliance and patient safety
The global Pharmacovigilance Outsourcing market is expected to be driven by the increasing drug approvals and regulatory safety requirements. Cost efficiency and global trial expansion boost outsourcing demand.
According to study, the global Pharmacovigilance Outsourcing market size was worth around USD 3.76 Billion in 2023 and is predicted to grow to around USD 13.05 Billion By 2032.
The global Pharmacovigilance Outsourcing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 14.84% during the forecast period from 2024-2032.
The global Pharmacovigilance Outsourcing industry is projected to be challenged by Challenges include data quality issues, regulatory compliance complexity, and confidentiality risks.
The Opportunities include rising clinical trial volumes, post-market surveillance demand, cost optimization for pharma companies, and global regulatory requirements will offer significant growth opportunities in the Pharmacovigilance Outsourcing market.
AI-driven adverse event detection; regulatory compliance across regions; cost-efficient outsourcing for global pharma companies are the emerging trends and innovations impacting the Pharmacovigilance Outsourcing market.
The global Pharmacovigilance Outsourcing market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Pharmacovigilance Outsourcing market are; Genpact, Bioclinica, Tata Consultancy Services (TCS), Accenture, PRA Health Sciences, Clintec, SIRO Clinpharm, CliniRx Tangent Research, Covance, Infosys, Tech Mahindra, Cognizant, Ergomed, IBM, HCL Technologies, iGATE, ICON, iMED Global, Medpace Holdings, IQVIA, Oracle, Novartis, Parexel, Symogen, and Syneos Health and others.
The report explores crucial aspects of the Pharmacovigilance Outsourcing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
